AI-driven company anumana partnered with Novartis to drive the development of its electrocardiogram (ECG) AI algorithms to detect subclinical heart disease.
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
LoveDepot.com addresses this gap that is yawning in the market
Deucravacitinib is currently under regulatory review in multiple regions, including the U.S., Europe and Japan, and would be the first selective allosteric tyrosine kinase 2 (TYK2) inhibitor approved for the treatment of any disease
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The facility is among 12 centres established worldwide, and the first in Asia
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
The peptide-based vaccine induces a t cell-dependent response
Essent continues to broaden its highly characterized, low passage primary cell catalog
UCB plans to submit regulatory applications in Q3 2022
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
